Cerecor released clinical results from a sponsored trial on CERC-501 in treatment-resistant depression.
Advanced Proteome Therapeutics has been accepted into the Johnson & Johnson innovation laboratories in Toronto.
DiaMedica Therapeutics received a patent for DM199 from the US Patent and Trademark Office.
TG Therapeutics revealed preliminary results from an ongoing Phase 2 study of TG-1101 treating patients with relapsing forms of multiple...
MEDITE Cancer Diagnostics announced some restructuring plans for its German organization.
CorMedix announced an increase to its public offering, bringing the gross proceeds up to $12.1 million approximately.
MRI Interventions signed a licensing and collaborating agreement with Acoustic MedSystems.